The primary mechanisms include cytokine-mediated osteoclast activation (~60%), parathyroid hormone-related protein (PTHrP) secretion (~25%), and vitamin D dysregulation (~15%), the latter being more common in T-cell lymphomas [8]. Here, PTHLH is linked to T-cell non-Hodgkin lymphoma.